COVID-19 vaccine-maker AstraZeneca was in the spotlight in May following the company’s admission in a UK court proceeding of the possibility of a rare side effect, Thrombosis with Thrombocytopenia Syndrome (TTS) associated with its vaccines. More than 50 individuals have alleged the vaccine resulted in death and serious injuries from TTS.